Virginia AG Miyares Announces Nearly $110 Million in Opioid Settlement Payments

Jason Miyares

Virginia Attorney General Jason Miyares announced on Tuesday the receipt of more than $100 million in opioid settlement payments from drug manufacturers, distributors and pharmacies who agreed to the financial compensation for their role in the opioid crisis.

The press release by Miyares’ office explained the latest round of payments totaled about $108.4 million of the $1.1 billion secured by Virginia in opioid settlements.

Read the full story

Virginia to Receive $366 Million from Opioid Settlement

Virginia is slated to receive approximately $366 million as part of the $17.3 billion nationwide settlements with opioid manufacturers Teva and Allegan and pharmacies CVS and Walgreens, Attorney General Jason Miyares announced. 

“This milestone settlement with two major drug makers and two major pharmacies has been a long time coming,” said Miyares. “I look forward to seeing the positive impacts on our communities and lives this money will have across Virginia.”

Read the full story

Arizona Localities Receive Portion of National Opioid Settlement

Arizona Attorney General Kris Mayes announced the finalization of a $50 billion national opioid settlement against drug companies Teva and Allergan and pharmacies CVS and Walgreens.

Arizona will receive $380 million in compensation over 15 years. Approximately $213 million will go toward local governments, and the remaining $167 million will be allocated to state-level efforts.

Read the full story

Attorney General Yost Secures $679.6 Million From Settlement to Help Fund Opioid Recovery in Ohio

Ohio Attorney General Dave Yost announced that he along with 21 other attorneys general have secured final approval of a combined $17.3 billion settlement to hold two drug makers and two pharmacies accountable for their roles in the opioid-addiction crisis and help fund opioid recovery efforts.

Under the settlement, Ohio expects to receive a total of $679.6 million from drug makers Teva and Allergan and pharmacies CVS and Walgreens over the next 15 years.

Read the full story

Existing Ohio Law Protecting Unborn Babies Blocks FDA Approval of Pharmacy Distribution of Abortion Pills

The “Abortion Pill,” also known as RU-486, could previously only be prescribed by medical professionals in the United States. The Federal Drug Administration (FDA) has officially authorized pharmacy distribution of RU-486, but an Ohio law passed in 2004 forbids pharmacies from distributing these harmful pills.

The drug, commonly known as Mifepristone, has recently received FDA approval, and retailers like Walgreens and CVS across the U.S. have already declared they will stock it. In Ohio however, only doctors with specific training and certification can offer, sell, dispense, or administer the drugs.

Read the full story

Georgia Joins Walmart Opioid Settlement

The state of Georgia has signed on to a $3.1 billion national agreement with Walmart amid allegations that the retailer didn’t properly monitor opioids dispensing at its pharmacies; Georgia is expected to get $28 million in the deal, according to an announcement from Attorney General Chris Carr.

“The opioid epidemic has destroyed lives, families, and communities all across our state and nation,” Carr said in the release.

Read the full story

Wisconsin Attorney General: Agreements with CVS and Walgreens Over Opioid Crisis Finalized

Wisconsin Attorney General Josh Kaul (D) announced on Thursday that his and numerous other states have finalized an agreement whereby the CVS and Walgreens pharmacy companies will pay $10.7 billion to those jurisdictions over opioid-epidemic concerns. 

The deal comes as a result of litigation by prosecutors across the nation alleging that the corporations failed to ensure that their pharmacies properly dispense painkillers, resulting in illegal trafficking and use of the drugs that has contributed to widespread deadly addiction. 

Read the full story

Virginia Expects $60 Million in Tentative Opioid Crisis Settlement with Walmart

Virginia is expected to receive $60 million as part of a tentative $3.1 billion settlement agreement with Walmart after allegations of insufficient oversight of opioid dispensing at the chain’s pharmacies.

“Companies who facilitated the dispensing of opioids contributed to the opioid epidemic that has devastated millions of lives. This significant settlement will help us fight back against the epidemic and provide abatement and rehabilitation resources to suffering Virginians,” Attorney General Jason Miyares said in a press release.

Read the full story

Virginia Nurse Files Lawsuit Alleging CVS Fired Her for Refusing to Administer ‘Abortion-Causing Drugs’

The Alliance Defending Freedom has filed a lawsuit alleging that the CVS-owned MinuteClinic fired nurse practitioner Paige Casey from her northern Virginia job after Casey refused to violate her religious beliefs and provide “abortion-causing drugs.”

“Casey’s religious objection never posed an issue to coworkers, patients, or supervisors, and just two days before she was fired, she received a merit-based pay increase. For three and a half years, CVS respected Casey’s religious beliefs by allowing her to decline to provide or facilitate the use of abortion-inducing drugs. But in January, CVS informed her that they would no longer accommodate her faith and fired her a few months later—directly violating Virginia’s Conscience Clause,” the ADF said in a press release.

Read the full story

Raphael Warnock Swore off Corporate PAC Money – but Took Thousands from PACs Funded by Big Corporations

Sen. Raphael Warnock has collected tens of thousands of dollars in campaign donations from political action committees (PAC) funded by corporations this election cycle, records show. At the same time, the senator has said he’s “never taken a dime of corporate PAC money” and pledged not to do so.

Warnock’s campaign took $29,600 during the first and second quarters of 2022 from Democratic leadership PACs that have in turn accepted $1.6 million from corporate-backed PACs since 2003, according to Federal Election Commission records (FEC) reviewed by the Daily Caller News Foundation.

Read the full story

CVS to Hire 15,000 Employees in Preparation for Flu Season, COVID-19 Vaccine Rollout

CVS Health announced that it would bring on approximately 15,000 additional workers in preparation for the upcoming flu season and an expected rise in coronavirus cases before the distribution of an eventual vaccine.

The hirings will take place before the year’s end, the company said Monday in a statement. Though most of the positions are temporary, many could transition into full-time positions, CVS said.

Read the full story

CVS Will Hire 50,000 Workers, Company Announces

CVS Health plans on hiring 50,000 employees to fill full-time, part-time and temporary positions as the coronavirus pandemic continues to spread across the United States, the company announced on Monday.

Available roles include store associates, home delivery drivers, distribution center employees and customer service employees. CVS said many roles will be filled by employees from current CVS Health clients that have had to furlough workers, such as Hilton and Marriott.

Read the full story

Drug Pricing War That Led CVS and Walmart to Part Ways Will Disproportionately Impact Rural Communities

by Evie Fordham   Walmart and CVS Health’s pharmacy benefit management (PBM) division announced they’re parting ways Tuesday, and it’s a split that could disproportionately impact rural patients, health care entrepreneur Dave Chase told The Daily Caller News Foundation. The split was brought on by a pricing dispute and means that many people who have CVS Health drug plans will no longer be able to pick up their prescriptions at Walmart locations. “Walmart is in a lot of rural areas where there aren’t a lot of choices … I think it’s definitely troublesome for patients,” Chase, a health care author and co-founder of Health Rosetta, told TheDCNF in a telephone interview Tuesday. But Chase also emphasized Walmart’s “unassailable” reputation for making drugs affordable, including its $4 generic prescription drug program. Walmart maintained that CVS was trying to control where customers filled their prescriptions, according to Bloomberg. “We are committed to providing value to our customers across our business, including our pharmacy, but we don’t want to give that value to the middle man,” Walmart said in a statement to The Daily Caller News Foundation Tuesday. “This issue underscores the problems that can arise when a PBM can exert their unregulated…

Read the full story